Daiichi Sankyo, National Cancer Center enter research alliance

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2012

Singapore: National Cancer Center of Japan and pharma company Daiichi Sankyo have agreed to form a comprehensive resear...Read more

Phospagenics, Nippon Zoki to develop pain drug

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

Singapore: Australian drug delivery technology company Phosphagenics has extended its collaboration with its high calib...Read more

Japan's BIOtech 2013 witnesses 10,362 visitors

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2013

Singapore: BIOtech 2013 in Japan, which is one-of-the-largest bio events in Asia, concluded successfully. The event was ...Read more

Mystic gets Japan, China patent nod for containers

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

Singapore: Mystic Pharmaceuticals, US, received key notices of allowance from Asian patent offices in the company's ong...Read more

Century Medical gets Japanese nod for Glider catheter

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2013

‎Singapore: TriReme Medical's Japanese partner, Century Medical, has received Shonin approval for Glider PTCA cath...Read more

Stem cell industry has substantial growth potential

Japan |  Analysis | By Piyusha Chatterjee | 4 Comment | 31 Jan, 2013

The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...Read more

Ariad begins phase I/II trial of ponatinib in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

Singapore: Ariad Pharmaceuticals, an emerging global oncology company focused on discovery, development and commercializ...Read more

Eisai gets 6 months US exclusivity for Aciphex

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

Singapore: Eisai has been able to meet the US FDA's written request requirements for pediatric exclusivity for Aciphex ...Read more

Abbott starts Absorb Japan trial in CAD patients

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

Singapore: Abbott announced that it has initiated the Absorb Japan randomized controlled clinical trial to evaluate the ...Read more

Chugai seeks nod for breast cancer drug in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...Read more

Japanese stem cell researcher wins 2012 Nobel in medicine

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2012

Singapore: Dr Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), Kyoto University, ha...Read more

Chugai Pharma appoints new CMO

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2014

Singapore: Chugai Pharma USA, Berkeley Heights, NJ a wholly owned subsidiary of Chugai Pharmaceutical, Tokyo, Japan, mem...Read more

Japan to host its first-ever medicine expo in 2014

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: Japan is hosting its first personalised medicine and diagnostics expo in May 14-16, 2014.The Japanese governm...Read more

Medical devices: A hot segment in Japan

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devi...Read more

Eisai's Halaven now available in Spain

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

Singapore: Eribulin, an anticancer drug marketed by Japan-based Eisai under the trade name Halaven, has received reimbur...Read more

Europe to get new epilepsy drug from Eisai

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

Singapore: Eisai has decided to launch its AMPA receptor antagonist Fycompa (perampanel), a first-in-class anti-epilepti...Read more

What are the hurdles before stem cell research?

Japan |  Analysis | By Piyusha Chatterjee | 4 Comment | 31 Jan, 2013

The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...Read more

Takeda R&D filed 7 NDAs in the last 8 months

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...Read more